150 related articles for article (PubMed ID: 29533018)
21. Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.
Loizzi V; Cormio G; Nestola D; Falagario M; Surgo A; Camporeale A; Putignano G; Selvaggi L
Oncology; 2011; 81(2):91-7. PubMed ID: 21968290
[TBL] [Abstract][Full Text] [Related]
22. May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?
Garcia N; Bozzini N; Baiocchi G; da Cunha IW; Maciel GA; Soares Junior JM; Soares FA; Baracat EC; Carvalho KC
Hum Pathol; 2016 Apr; 50():43-50. PubMed ID: 26997437
[TBL] [Abstract][Full Text] [Related]
23. Androgen Receptor Expression in Endometrial Stromal Sarcoma: Correlation With Clinicopathologic Features.
Roy M; Kumar S; Bhatla N; Ray MD; Kumar L; Jain D; Phulware R; Mathur SR
Int J Gynecol Pathol; 2017 Sep; 36(5):420-427. PubMed ID: 28114189
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of Amphiregulin and the correlation with androgen receptor in invasive breast cancer.
Xiang G; Liu F; Liu J; Meng Q; Li N; Niu Y
Pathol Res Pract; 2019 Jun; 215(6):152414. PubMed ID: 31040043
[TBL] [Abstract][Full Text] [Related]
25. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study.
Cardillo MR; Petrangeli E; Aliotta N; Salvatori L; Ravenna L; Chang C; Castagna G
J Exp Clin Cancer Res; 1998 Jun; 17(2):231-7. PubMed ID: 9700586
[TBL] [Abstract][Full Text] [Related]
26. Androgen receptor expression in estrogen receptor-negative breast cancer. Immunohistochemical, clinical, and prognostic associations.
Agoff SN; Swanson PE; Linden H; Hawes SE; Lawton TJ
Am J Clin Pathol; 2003 Nov; 120(5):725-31. PubMed ID: 14608899
[TBL] [Abstract][Full Text] [Related]
27. Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.
Langner C; Ratschek M; Rehak P; Schips L; Zigeuner R
J Urol; 2004 Feb; 171(2 Pt 1):611-4. PubMed ID: 14713771
[TBL] [Abstract][Full Text] [Related]
28. The Impact of Androgen Receptor Expression on Endometrial Carcinoma Recurrence and Survival.
Mahdi Z; Abdulfatah E; Pardeshi V; Hassan O; Schultz D; Morris R; Cote ML; Elshaikh MA; Bandyopadhyay S; Ali-Fehmi R
Int J Gynecol Pathol; 2017 Sep; 36(5):405-411. PubMed ID: 28277313
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor (AR) expression is an independent unfavorable prognostic factor in gastric cancer.
Kominea A; Konstantinopoulos PA; Kapranos N; Vandoros G; Gkermpesi M; Andricopoulos P; Artelaris S; Savva S; Varakis I; Sotiropoulou-Bonikou G; Papavassiliou AG
J Cancer Res Clin Oncol; 2004 May; 130(5):253-8. PubMed ID: 14963700
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
Wien Klin Wochenschr; 2004 Feb; 116(4):135-9. PubMed ID: 15038405
[TBL] [Abstract][Full Text] [Related]
32. Male breast cancer: Looking for better prognostic subgroups.
Abreu MH; Afonso N; Abreu PH; Menezes F; Lopes P; Henrique R; Pereira D; Lopes C
Breast; 2016 Apr; 26():18-24. PubMed ID: 27017238
[TBL] [Abstract][Full Text] [Related]
33. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
[TBL] [Abstract][Full Text] [Related]
35. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma.
Raut CP; Nucci MR; Wang Q; Manola J; Bertagnolli MM; Demetri GD; Morgan JA; Muto MG; Fletcher CD; George S
Eur J Cancer; 2009 Nov; 45(16):2818-24. PubMed ID: 19647426
[TBL] [Abstract][Full Text] [Related]
36. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
37. Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers.
Castellano I; Allia E; Accortanzo V; Vandone AM; Chiusa L; Arisio R; Durando A; Donadio M; Bussolati G; Coates AS; Viale G; Sapino A
Breast Cancer Res Treat; 2010 Dec; 124(3):607-17. PubMed ID: 20127405
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in early-stage leiomyosarcoma of the uterus.
Pelmus M; Penault-Llorca F; Guillou L; Collin F; Bertrand G; Trassard M; Leroux A; Floquet A; Stoeckle E; Thomas L; MacGrogan G
Int J Gynecol Cancer; 2009 Apr; 19(3):385-90. PubMed ID: 19407564
[TBL] [Abstract][Full Text] [Related]
39. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
Lu B; Shi H; Zhang X
Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
[TBL] [Abstract][Full Text] [Related]
40. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
